Use Able AI chat for product recommendations

ULBP2 Polyclonal antibody

ULBP2 Polyclonal Antibody for WB, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, ELISA

ALCAN alpha, N2DL 2, N2DL2, NKG2D ligand 2, NKG2DL2, RAET1H, UL16 binding protein 2, ULBP2

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for ULBP2 in ?

Tested Applications

Positive WB detected inJurkat cells
Positive IHC detected inhuman liver cancer tissue, human gliomas tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:500-1:2000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

13133-1-AP targets ULBP2 in WB, IHC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag3798

Product name: Recombinant human ULBP2 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 25-224 aa of BC034689

Sequence: AGRADPHSLCYDITVIPKFRPGPRWCAVQGQVDEKTFLHYDCGNKTVTPVSPLGKKLNVTTAWKAQNPVLREVVDILTEQLRDIQLENYTPKEPLTLQARMSCEQKAEGHSSGSWQFSFDGQIFLLFDSEKRMWTTVHPGARKMKEKWENDKVVAMSFHYFSMGDCIGWLEDFLMGMDSTLEPSAGAPLAMSSGTTQLRA

Predict reactive species
Full Name UL16 binding protein 2
Calculated Molecular Weight 246 aa, 27 kDa
Observed Molecular Weight 30 kDa
GenBank Accession NumberBC034689
Gene Symbol ULBP2
Gene ID (NCBI) 80328
RRIDAB_2214691
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ9BZM5
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

NKG2D is an activating cell surface receptor that is predominantly expressed on cytotoxic immune cells. NKG2D recognizes a wide range of ligands. In humans, the NKG2D ligand (NKG2DL) includes MICA, MICB, and six members of the ULBP family (ULBP1-6) (PMID: 29568297; 30813924). ULBPs are MHC class I-related molecules (PMID: 11239445). ULBP2 contains two Ig-like domains, the alpha-1 and alpha-2 domains characteristic of the MHC class I family, but lacks the alpha-3 domain. It can be expressed as either a transmembrane or GPI-linked protein, or released from the cell surface (PMID: 21224393; 24614922). ULBP2 binds and activates the NKG2D, mediating the recruitment and activation of NK cells.

Protocols

Product Specific Protocols
IHC protocol for ULBP2 antibody 13133-1-APDownload protocol
WB protocol for ULBP2 antibody 13133-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The ULBP2 Polyclonal antibody (Cat# 13133-1-AP) has 6 total citations. These appear in journals including Cell Death & Disease, Cancer Letters, International Journal of Biological Sciences, International Immunopharmacology, Cell Oncology, and Journal of Stomatology, Oral and Maxillofacial Surgery. The research fields span cancer immunotherapy, NK cell biology, and tumor progression in gastric cancer, liver cancer, AML, triple-negative breast cancer, and head and neck squamous cell carcinoma.

SpeciesApplicationTitle
humanIHC

Cell Death Dis

ULBP2 CAR-T cells enhance gastric cancer immunotherapy by inhibiting CAF activation.

Authors - Wentao Zhang
humanWB

Cancer Lett

Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer

Authors - Deli Mao
humanWB

Int J Biol Sci

CD44 3'-Untranslated Region Functions as a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression.

Authors - Jun Weng
humanWB

Cell Oncol (Dordr)

TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulation.

Authors - Jia Liu
humanWB

Int Immunopharmacol

Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway.

Authors - Hui-Yang Wu
humanWB

J Stomatol Oral Maxillofac Surg

ULBP2 promotes progression of head and neck squamous cell carcinoma by modulating MAPK signaling pathway

Authors - Wei Xu
  • KD Validated
Loading...
||
New chat

Able™

正在加载,请稍候...